Huadong Medicine Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021
October 26, 2021 at 08:32 am EDT
Huadong Medicine Co., Ltd reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 25,927.48 million compared to CNY 25,500.88 million a year ago. Revenue was CNY 25,927.48 million compared to CNY 25,500.88 million a year ago. Net income was CNY 1,895.38 million compared to CNY 2,391.47 million a year ago. Basic earnings per share from continuing operations was CNY 1.0832 compared to CNY 1.3667 a year ago. Diluted earnings per share from continuing operations was CNY 1.0832 compared to CNY 1.3667 a year ago.